4//SEC Filing
Kristal Robert Eugene 4
Accession 0001567619-23-003328
CIK 0001505497other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:32 PM ET
Size
7.5 KB
Accession
0001567619-23-003328
Insider Transaction Report
Form 4
Kristal Robert Eugene
Chief Financial Officer
Transactions
- Award
Stock Option
2023-02-17+88,968→ 88,968 totalExercise: $2.91Exp: 2033-02-17→ Common Stock (88,968 underlying)
Holdings
- 10,490
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (10,490 underlying) - 7,994
Common Stock
Footnotes (2)
- [F1]The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
- [F2]The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.
Documents
Issuer
BioRestorative Therapies, Inc.
CIK 0001505497
Entity typeother
Related Parties
1- filerCIK 0001893955
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:32 PM ET
- Size
- 7.5 KB